New patent for Amylyx drug RELYVRIO

Annual Drug Patent Expirations for RELYVRIO Relyvrio is a drug marketed by Amylyx and is included in one NDA. It is available from one supplier. There are four patents protecting…

The post New patent for Amylyx drug RELYVRIO appeared first on DrugPatentWatch - Make Better Decisions.

Comments are closed.